December 2, 2025: Modest Growth for Ozempic Gastroparesis MDL There are now 2,947 active lawsuits in the MDL focused on claims involving GLP-1 drugs and intestinal conditions like gastroparesis
They delivered all requested data on time and within the agreed scope
Understanding what GLP-1 drugs are, how they are delivered, and what is known about patch products can help patients make safer, more informed decisions
PRISMA, preferred reporting items for systematic reviews and meta-analyses
If you never felt sick whatsoever, you still got 90% of the weight-loss benefits from tirzepatide (Zepbound, Eli Lilly), Drucker said
Buyer Takeaway: The enrollment process is designed to be fast